Similarly, i.t. administration of Flt3L, local radiotherapy, and TLR3 stimulation followed by surgical resection demonstrated a potential multimodal therapy that can generate tumor-specific CTLs, achieve improved systemic tumor remission from 40% to 80%, and delay metastases in highly metastatic tumors [180]. This evidence concerns the gene TLR3 and neoplasm.